mimosine has been researched along with Malignant Melanoma in 3 studies
Mimosine: 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The anticancer activity of a series of novel synthesized, hydroxypyridone-based metal chelators (analogues of L-mimosine) was evaluated in an in vitro model of melanoma consisting of malignant melanoma (A375), non-melanoma epidermoid carcinoma (A431) and immortalized non-malignant keratinocyte (HaCaT) cells." | 7.96 | Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma. ( Cheung, W; Kyriakou, S; Mantso, T; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Tetard, D; Todryk, S; Veuger, S, 2020) |
| "Melanoma is an aggressive and highly metastatic type of skin cancer where the design of new therapies is of utmost importance for the clinical management of the disease." | 5.62 | A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma. ( Anestopoulos, I; Cheung, W; Franco, R; Kyriakou, S; Mantso, T; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Tetard, D; Trafalis, DT; Veuger, S, 2021) |
| "The anticancer activity of a series of novel synthesized, hydroxypyridone-based metal chelators (analogues of L-mimosine) was evaluated in an in vitro model of melanoma consisting of malignant melanoma (A375), non-melanoma epidermoid carcinoma (A431) and immortalized non-malignant keratinocyte (HaCaT) cells." | 3.96 | Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma. ( Cheung, W; Kyriakou, S; Mantso, T; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Tetard, D; Todryk, S; Veuger, S, 2020) |
| "Melanoma is an aggressive and highly metastatic type of skin cancer where the design of new therapies is of utmost importance for the clinical management of the disease." | 1.62 | A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma. ( Anestopoulos, I; Cheung, W; Franco, R; Kyriakou, S; Mantso, T; Mitsiogianni, M; Panayiotidis, MI; Pappa, A; Tetard, D; Trafalis, DT; Veuger, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kyriakou, S | 2 |
| Cheung, W | 2 |
| Mantso, T | 2 |
| Mitsiogianni, M | 2 |
| Anestopoulos, I | 1 |
| Veuger, S | 2 |
| Trafalis, DT | 1 |
| Franco, R | 1 |
| Pappa, A | 2 |
| Tetard, D | 2 |
| Panayiotidis, MI | 2 |
| Todryk, S | 1 |
| Hashiguchi, H | 1 |
| Takahashi, H | 1 |
3 other studies available for mimosine and Malignant Melanoma
| Article | Year |
|---|---|
A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Ceramides; Flow Cytometry; Humans; Mela | 2021 |
Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line; Cell | 2020 |
Inhibition of two copper-containing enzymes, tyrosinase and dopamine beta-hydroxylase, by L-mimosine.
Topics: Adrenal Medulla; Animals; Catechol Oxidase; Cattle; Copper; Dopamine beta-Hydroxylase; Drug Interact | 1977 |